Research & Development

迅雷俺来也俺来嫖7岁当CEO 美国小男孩靠垃圾分类走上"人生巅峰"


  雲瑯的話讓曹襄再次打了一個哆嗦︰“狗日的聶壹好狠!”   “霍去病!”迅雷   等他跑到懷化公主寢宮的時候,甦稚已經在忙碌了。俺来也   他相信,霍去病一定就在黑暗中看著他。俺来嫖   匈奴人沖進羊盤之後,梟盡就看到身後的火光了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo